Sunday, January 29, 2017

Drugmaker Novo Nordisk bets $145 million on post-Brexit UK science

Reuters: Health News
LONDON (Reuters) - Novo Nordisk, the world's top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit.
at

No comments:

Post a Comment